Transamerica Financial Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
AWM
VCM
CIC
Transamerica Financial Advisors's IHE Position: Q1 2024 in Review
Transamerica Financial Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2024, closing a stake of 3 shares — an estimated $1K sold.
Transamerica Financial Advisors first reported a position in IHE in Q1 2014 and held it in 23 quarters. The position peaked at $340K in Q2 2017. 143 funds tracked by Wall St. Rank hold IHE as of Q1 2024.
- Transamerica Financial Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
- Transamerica Financial Advisors sold 3 iShares US Pharmaceuticals ETF shares in Q1 2024, an estimated $1K.
- Transamerica Financial Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 23 quarters.
- Transamerica Financial Advisors's iShares US Pharmaceuticals ETF position peaked at $340K in Q2 2017.
- 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2024.
Based on Transamerica Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.